Aurisco Pharmaceutical Co., Ltd, Tiantai, China – FDA Inspections

Inspection records and compliance data for Aurisco Pharmaceutical Co., Ltd in Tiantai, -. 4 FDA inspections on record, 1 Form 483, last inspected March 21, 2025.

Company Profile

This profile covers Aurisco Pharmaceutical Co., Ltd based in Tiantai, China.

FDA Inspection History

FDA inspections: 4
OAI: 0
VAI: 0
NAI: 2
Unclassified: 2
Form 483s: 1
Warning letters: 0

First inspected November 15, 2013. Last inspected March 21, 2025.

FDA inspections (4)

Date	Result	FDA center(s)	Insp. #
March 21, 2025	Not classified	Animal Drugs & Feeds, Human Drugs	1269298
January 25, 2019	Not classified	Human Drugs	1079222
November 30, 2018	NAI	Human Drugs · Drug Quality Assurance	1077584
November 15, 2013	NAI	Human Drugs · Drug Quality Assurance	856482

FDA documents

No Form 483s, Warning Letters or EIRs on record.

Related Companies (10)

Companies with similar regulatory profiles, compliance history, and operations.

EUROAPI FRANCE

FDC Limited (Roha Plant)

Kyowa Pharma Chemical Co Ltd

Excella GmbH & Co. KG

Alexion Pharma International Operations Unlimited Co.

Orchid Pharma Ltd.

Merck Life Science Technologies (Nantong) Co., Ltd.

Jiangsu Hansoh Pharmaceutical Group Co., Ltd.

Qilu Pharmaceutical Co., Ltd.

Reactimex S.A. de C.V.